Over 1,000 drug discovery professionals attend Discovery on Target (DOT), the industry’s preeminent event on novel drug targets and technologies, each year. DOT highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules. This year’s topics include proteomics, small G proteins, disease modeling, preclinical oncology models and tools, CNS, gene and cell therapy, and biomarkers.
Get 10% off your first website order with promo code SHOPONLINE10 Hurry! Offer ends soon.